Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.035 USD | +194.12% | +159.26% | -43.55% |
2023 | Psycheceutical Bioscience, Inc. kündigt Wechsel im Vorstand an | CI |
2023 | Psycheceutical Bioscience, Inc. ernennt Neilank K. Jha zum neuen Executive Chairman | CI |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Julian Bailes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anish Tuteja
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Zapolin
PRN | Corporate Officer/Principal | - | - |
Aric Logsdon
PRN | Corporate Officer/Principal | - | 29.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bruce Cassidy
BRD | Director/Board Member | 74 | - |
Michael Gurin
BRD | Director/Board Member | - | - |
Michael Hlavsa
DFI | Director of Finance/CFO | 70 | - |
Neilank K. Jha
CEO | Chief Executive Officer | - | 12.12. |
Julian Bailes
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chadwick Harman
COO | Chief Operating Officer | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 276 427 437 | 68 797 013 ( 24,89 %) | 0 | 24,89 % |
Aktie B | 0 | 161 700 | 0 | 0 |
Unternehmenskontakt
Psycheceutical Bioscience, Inc.
515 East Las Olas Boulevard Suite 120
33301, Fort Lauderdale
+
http://www.psycheceutical.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-43.55% | 25.63 Mio. | |
+33.63% | 50.93 Mrd. | |
-0.09% | 42.12 Mrd. | |
+49.62% | 42.05 Mrd. | |
-4.96% | 29.18 Mrd. | |
+11.18% | 26.02 Mrd. | |
-21.95% | 18.9 Mrd. | |
+8.61% | 13.21 Mrd. | |
+24.73% | 12.17 Mrd. | |
+28.31% | 12.16 Mrd. |
- Börse
- Aktien
- A3D1PX Aktie
- Unternehmen Blue Water Ventures International, Inc.